64 results
Page 3 of 4
8-K
EX-99.1
599h7h whqv
21 Jan 21
Heron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy Surgery
8:40am
8-K
EX-99.2
0jt 8gjpwkrxfgz11j
11 Jan 21
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program
8:40am
8-K
EX-99.1
1eh15
11 Jan 21
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program
8:40am
8-K
EX-99.1
el3cljctwha2lrg
13 Nov 20
Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Treatment of Postoperative Pain
8:40am
8-K
EX-99.1
6yf2e4 ams2sbr
5 Nov 20
Results of Operations and Financial Condition
8:40am
8-K
EX-99.1
jefejo80 2eq7s4
28 Sep 20
Heron Therapeutics Receives European Commission Authorization for ZYNRELEFTM (HTX-011) for the Treatment of Postoperative Pain
8:41am
8-K
EX-99.1
ya9sa t7m
16 Sep 20
Regulation FD Disclosure
8:40am
8-K
EX-99.1
d1px5t37czwxs
8 Sep 20
Heron Therapeutics Announces Successful Outcome of FDA Type A Meeting to Discuss HTX-011 for the Management of Postoperative Pain
8:41am
8-K
EX-99.1
esp5a1
5 Aug 20
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.1
d67iy 8i57d1
16 Jul 20
Heron Therapeutics Announces Initiation of
8:40am